STTK
Price:
$1.11
Market Cap:
$52.99M
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is in Phase 1 clinical trial in patients with advanced solid tumors and lymphoma. The company was incorporated in 2016 and is headquartered in Austin, Texas.[Read more]
Industry
Biotechnology
IPO Date
2020-10-09
Stock Exchange
NASDAQ
Ticker
STTK
According to Shattuck Labs, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.73. This represents a change of -81.06% compared to the average of -3.85 of the last 4 quarters.
The mean historical PE Ratio of Shattuck Labs, Inc. over the last ten years is -24.59. The current -0.73 PE Ratio has changed 196.93% with respect to the historical average. Over the past ten years (40 quarters), STTK's PE Ratio was at its highest in in the December 2021 quarter at 11.46. The PE Ratio was at its lowest in in the December 2020 quarter at -42.32.
Average
-24.59
Median
-20.94
Minimum
-61.77
Maximum
-0.97
Discovering the peaks and valleys of Shattuck Labs, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 258.96%
Maximum Annual PE Ratio = -0.97
Minimum Annual Increase = -87.98%
Minimum Annual PE Ratio = -61.77
Year | PE Ratio | Change |
---|---|---|
2023 | -3.48 | 258.96% |
2022 | -0.97 | -87.98% |
2021 | -8.07 | -86.94% |
2020 | -61.77 | 82.65% |
2019 | -33.82 | -14.16% |
The current PE Ratio of Shattuck Labs, Inc. (STTK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-4.17
5-year avg
-21.62
10-year avg
-24.59
Shattuck Labs, Inc.’s PE Ratio is greater than C4 Therapeutics, Inc. (-2.55), less than Eliem Therapeutics, Inc. (0), less than Prelude Therapeutics Incorporated (-0.69), greater than Monte Rosa Therapeutics, Inc. (-4.84), greater than Foghorn Therapeutics Inc. (-3.45), greater than Kymera Therapeutics, Inc. (-18.55), greater than Nurix Therapeutics, Inc. (-8.05), greater than Pardes Biosciences, Inc. (-1.36), greater than Champions Oncology, Inc. (-178.90), less than Century Therapeutics, Inc. (-0.67), greater than PMV Pharmaceuticals, Inc. (-1.47), greater than Stoke Therapeutics, Inc. (-6.05),
Company | PE Ratio | Market cap |
---|---|---|
-2.55 | $273.18M | |
0 | $342.68M | |
-0.69 | $64.12M | |
-4.84 | $433.13M | |
-3.45 | $279.08M | |
-18.55 | $2.64B | |
-8.05 | $1.39B | |
-1.36 | $135.19M | |
-178.90 | $108.76M | |
-0.67 | $87.15M | |
-1.47 | $76.07M | |
-6.05 | $599.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shattuck Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shattuck Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Shattuck Labs, Inc.'s PE Ratio?
How is the PE Ratio calculated for Shattuck Labs, Inc. (STTK)?
What is the highest PE Ratio for Shattuck Labs, Inc. (STTK)?
What is the 3-year average PE Ratio for Shattuck Labs, Inc. (STTK)?
What is the 5-year average PE Ratio for Shattuck Labs, Inc. (STTK)?
How does the current PE Ratio for Shattuck Labs, Inc. (STTK) compare to its historical average?